Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.91 is 59% below its 5-year average of 7.18, near the low end of its 5-year range (1.27–25.29).
As of the fiscal period ended Tuesday, June 30, 2026. 2.77% below its 12-month average of 2.99.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.91.
QUICK RATIO (ACID-TEST)
2.91
QUICK RATIO (ACID-TEST) AVG TTM
2.99
QUICK RATIO (ACID-TEST) AVG 3Y
6.62
QUICK RATIO (ACID-TEST) AVG 5Y
7.18
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.77%
CURRENT VS 3Y AVG
-56.01%
CURRENT VS 5Y AVG
-59.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-13.09%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$44.72M
Quick Ratio (Acid-Test)
2.91
TTM Avg
2.99
3Y Avg
6.62
5Y Avg
7.18
Market Cap
$44.49M
Quick Ratio (Acid-Test)
1.92
TTM Avg
2.71
3Y Avg
2.94
5Y Avg
3.18
Market Cap
$45.73M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.22
3Y Avg
0.27
5Y Avg
0.92
Market Cap
$43.94M
Quick Ratio (Acid-Test)
0.89
TTM Avg
0.70
3Y Avg
0.40
5Y Avg
0.30
Market Cap
$43.14M
Quick Ratio (Acid-Test)
1.51
TTM Avg
2.91
3Y Avg
4.32
5Y Avg
5.30
Market Cap
$43.06M
Quick Ratio (Acid-Test)
2.59
TTM Avg
4.64
3Y Avg
4.51
5Y Avg
11.47
Market Cap
$47.27M
Quick Ratio (Acid-Test)
21.67
TTM Avg
27.64
3Y Avg
19.68
5Y Avg
18.08
Market Cap
$42.07M
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.00
3Y Avg
1.05
5Y Avg
1.35
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.72M | 2.91 | 2.99 | 6.62 | 7.18 |
| DarioHealth Corp. (DRIO)vs › | $44.49M | 1.92 | 2.71 | 2.94 | 3.18 |
| Celularity Inc. (CELU)vs › | $45.73M | 0.08 | 0.22 | 0.27 | 0.92 |
| SANUWAVE Health Inc. (SNWV)vs › | $43.94M | 0.89 | 0.70 | 0.40 | 0.30 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.14M | 1.51 | 2.91 | 4.32 | 5.30 |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.06M | 2.59 | 4.64 | 4.51 | 11.47 |
| CVRx, Inc. (CVRX)vs › | $42.99M | 6.87 | 8.83 | 11.21 | 12.90 |
| Instil Bio, Inc. (TIL)vs › | $47.27M | 21.67 | 27.64 | 19.68 | 18.08 |
| Precipio, Inc. (PRPO)vs › | $42.07M | 1.56 | 1.00 | 1.05 | 1.35 |
| BioStem Technologies, Inc. (BSEM)vs › | $42.63M | 0.76 | 2.59 | 1.53 | 1.04 |
Quick Ratio
2.91
Excludes inventory
Current Ratio
2.91
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.91 |
| 2026-03-31 | 1.27 |
| 2025-12-31 | 1.62 |
| 2025-09-30 | 3.87 |
| 2025-06-30 | 5.30 |
| 2025-03-31 | 8.09 |
| 2024-12-31 | 7.45 |
| 2024-09-30 | 10.10 |
| 2024-06-30 | 12.13 |
| 2024-03-31 | 6.71 |
| 2023-12-31 | 7.14 |
| 2023-09-30 | 9.63 |
| 2023-06-30 | 9.82 |
| 2023-03-31 | 7.21 |
| 2022-12-31 | 5.84 |
| 2022-09-30 | 5.45 |
| 2022-06-30 | 5.08 |
| 2022-03-31 | 13.19 |
| 2021-12-31 | 13.56 |
| 2021-09-30 | 22.43 |
| 2021-06-30 | 25.29 |
| 2021-03-31 | 15.69 |
| 2020-12-31 | 17.58 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
